Premium
Nalanda Capital, an India-focused private equity-style investor in public equities, has picked up a stake in a company that had received the backing of global healthcare-focused fund OrbiMed last year. Singapore-based Nalanda has invested around Rs 110.5 crore (around $15 million) for about a 4% stake in Advanced Enzyme Technologies Ltd, ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
